dbo:abstract
|
- BHF-177 is a compound used in scientific research which acts as a positive allosteric modulator at the GABAB receptor. It was shown to reduce self-administration of nicotine in animal studies. (en)
|
dbo:casNumber
| |
dbo:fdaUniiCode
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 3017 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chemspiderid
| |
dbp:f
| |
dbp:h
| |
dbp:iupacName
|
- N-[-bicyclo[2.2.1]hept-2-yl]-2-methyl-5-[4-phenyl]-4-pyrimidinamine (en)
|
dbp:iupharLigand
| |
dbp:n
| |
dbp:smiles
|
- C4CC2CC4CC2Nc1ncncc1-c3ccccc3 (en)
|
dbp:stdinchi
| |
dbp:stdinchikey
|
- ADHZHPOKTRHZGT-DXCKQFNASA-N (en)
|
dbp:unii
| |
dbp:verifiedrevid
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- BHF-177 is a compound used in scientific research which acts as a positive allosteric modulator at the GABAB receptor. It was shown to reduce self-administration of nicotine in animal studies. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |